Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Apollo Endosurgery Inc (APEN)

Apollo Endosurgery Inc (APEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 238,235
  • Shares Outstanding, K 28,703
  • Annual Sales, $ 42,050 K
  • Annual Income, $ -22,610 K
  • 60-Month Beta 2.19
  • Price/Sales 5.74
  • Price/Cash Flow N/A
  • Price/Book 92.54
Trade APEN with:

Options Overview Details

View History
  • Implied Volatility 92.09%
  • Historical Volatility 54.05%
  • IV Percentile 15%
  • IV Rank 10.87%
  • IV High 189.40% on 03/01/21
  • IV Low 80.23% on 05/27/21
  • Put/Call Vol Ratio 0.41
  • Today's Volume 86
  • Volume Avg (30-Day) 77
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 610
  • Open Int (30-Day) 901

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.30
  • Number of Estimates 1
  • High Estimate -0.30
  • Low Estimate -0.30
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -172.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.11 +9.86%
on 10/18/21
10.01 -10.99%
on 09/27/21
-0.16 (-1.76%)
since 09/22/21
3-Month
7.04 +26.56%
on 07/29/21
10.04 -11.25%
on 09/13/21
+0.93 (+11.65%)
since 07/22/21
52-Week
1.61 +453.42%
on 10/27/20
10.04 -11.25%
on 09/13/21
+7.20 (+421.05%)
since 10/22/20

Most Recent Stories

More News
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...

APEN : 8.95 (+0.34%)
Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...

APEN : 8.95 (+0.34%)
Apollo Endosurgery Announces Commencement of Public Offering of Common Stock

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...

APEN : 8.95 (+0.34%)
Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

- Revenue expected between $16.0 million and $16.4 million - Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% - Submitted a De Novo 510(k) Classification Request...

APEN : 8.95 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for...

See More

Key Turning Points

3rd Resistance Point 9.64
2nd Resistance Point 9.37
1st Resistance Point 9.14
Last Price 8.95
1st Support Level 8.65
2nd Support Level 8.38
3rd Support Level 8.16

See More

52-Week High 10.04
Last Price 8.95
Fibonacci 61.8% 6.82
Fibonacci 50% 5.82
Fibonacci 38.2% 4.83
52-Week Low 1.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar